Molecular Diagnostics, the IVD industry’ segment, refers to the tests measuring DNA and RNA, as well as various products of metabolism to discover mutations, specific genotypes or any biochemical alterations which may be linked to certain health states or disease conditions. This science owns its emergence to the advancements in biology that have deepened the knowledge of the mechanisms of molecular-level processes, both normal and malignant.
Molecular Diagnostics is by far the most hastily progressing sector. The oncoming decade will be ear-marked by far-reaching advances in reagent and automation systems, along with the advent of a generous assortment of novelties set to inevitably call for innovative marketing techniques. The percentage of market penetration into day-to-day habitual clinical lab settings, though, will revolve around the arrival of money’s worth and automatized systems with amplification techniques. Some of the firms reigning over the market are Abbott Diagnostics, Celera, Sysmex Corporation, Roche Diagnostics, Qiagen N.V., Siemens Medical Solutions Diagnostics, and more.
The research reports from this Catalogue look at the Molecular Diagnostics Market on every imaginable geography level, covering key technology and medical trends. The issues mentioned in the research reports are varied, ranging from market sizing, share and segmentation to new product introductions and regulatory landscape. Further, the research reports highlight market penetration strategies, potential enter barriers, competitive profiles, besides offering the Molecular Diagnostics Market forecasts.
Publications found:
657
Sort by:
Global Molecular Diagnostics Market (2016 - 2022)
US$ 3,600.00
... market growth. However, high cost of molecular equipment and delay in the approval of new molecular diagnostics tests could restraint growth of molecular diagnostic market. The Molecular Diagnostics Market ... ,101. Additionally, According to the statistics in 2016, approximately 5.1 million people are living with ...
February 2017
422 pages
Asia-Pacific Molecular Diagnostics Market (2016 - 2022)
US$ 1,500.00
... diagnostics. Hence, Asia- Pacific is expected to capture largest share in the market owing to increase in infectious diseases and innovation of personalized medicines. The Molecular Diagnostics Market ...
February 2017
130 pages
Europe Molecular Diagnostics Market (2016 - 2022)
US$ 1,500.00
... , Point to care diagnostics, Cell free DNA in clinical oncology is playing vital role in the growth of molecular diagnostics market. According to the fourth conference on molecular diagnostics Europe held in 2016, it has ... launched new range of products in molecular diagnostics. Hence, it could be expected that innovative technology could be leading the growth of molecular diagnostics market in Europe. The Molecular Diagnostics Market is segmented on the basis ...
February 2017
130 pages
LAMEA Molecular Diagnostics Market (2016 - 2022)
US$ 1,500.00
... & infectious diseases and technological advancements is leading the market for molecular diagnostics market in LAMEA. According to the report by Avert in 2016, In Latin America, 1.6 people and In Brazil 830 ... Africa, Nigeria and Rest of LAMEA. The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report ...
February 2017
130 pages
North America Molecular Diagnostics Market (2016 - 2022)
US$ 1,500.00
... most effected region is North America. Hence, it could be expected that high prevelance of diseases could result in growth of molecular devices market in North America. The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented ...
February 2017
106 pages
2017 Argentina Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Bahrain Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Bangladesh Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Brazil Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Chile Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 China Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Colombia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Croatia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Hong Kong Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
January 2017
1120 pages
2017 India Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Indonesia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Iran Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Iraq Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Israel Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Jordan Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Kuwait Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Lebanon Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Malaysia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Mexico Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Myanmar Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 New Zealand Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology ... , and others LCR Companies, universities and research centers developing new molecular- diagnostic technologies and products. Competitive Assessments Strategic profiles of major suppliers ...
January 2017
1120 pages
2017 Oman Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Pakistan Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Peru Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Philippines Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Qatar Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Saudi Arabia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
January 2017
1120 pages
2017 Serbia Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Singapore Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 South Korea Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support ... over 30 NAT assays. Product/Technology Review Comparison of leading molecular diagnostic analyzers. Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation ...
January 2017
1120 pages
2017 Taiwan Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
2017 Thailand Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
US$ 3,825.00
... and consumable suppliers Rationale The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years ... presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating ...
January 2017
1120 pages
